Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244

Publication year:
All
11 - 14 out of 14Page size: 10
  1. 2019
  2. Published

    Molecular Perturbations in Cholangiocarcinoma: Is it Time for Precision Medicine?

    Braconi, C., Roessler, S., Kruk, B., Lammert, F., Krawczyk, M. & Andersen, Jesper Bøje, 2019, In: Liver International. 39, Suppl. 1, p. 32-42 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    THU-491-The role of alanine glyoxylate aminotransferase in hepatocellular carcinoma

    Satriano, L., Lewinska, Monika, Rourke, C. O., Oliveira, D. V., Bhatt, D. K., Taranta, A., Herr, M., Straub, B., Conner, D. E. A., Budhu, D. A., Pomyen, Y., Ma, Tao, Gerhart-Hines, Zach, Stjernegaard, D. C. S., Matter, M., Crocoll, D. C., Wang, X. W., Marquardt, J. & Andersen, Jesper Bøje, 2019, p. e377.

    Research output: Contribution to conference › Poster › Research

  4. Published

    The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

    Di Maira, G., Gentilini, A., Pastore, M., Caligiuri, A., Piombanti, B., Raggi, C., Rovida, E., Lewinska, Monika, Andersen, Jesper Bøje, Borgo, C., Salvi, M., Ottaviani, D., Ruzzene, M. & Marra, F., 2019, In: Oncogenesis. 8, 11, p. 61-72 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Therapeutic Potential of Pharmacoepigenetics in Cholangiocarcinoma

    O'Rourke, Colm, Satriano, L., Oliveira, D. V. N. P., Munoz-Garrido, P. & Andersen, Jesper Bøje, 2019, Pharmacoepigenetics. Academic Press, p. 551-562 12 p.

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Previous 1 2 Next

ID: 93714085